AptarGroup CEO: China is unfazed by Trump's tariffs because their ‘grit and sheer willpower is on a different scale' [Yahoo! Finance]
AptarGroup, Inc. (NYSE:ATR) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? [Yahoo! Finance]
AptarGroup CEO: China is unfazed by Trump's tariffs because their ‘grit and sheer willpower is on a different scale' [Fortune]
Nasus Pharma CEO Issues 2025 Letter to Shareholders [Yahoo! Finance]
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)